RK

Rupa Khushmanlal Patel

Director Director DIN 08016379
DIN 08016379 First appointment Dec 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2017
Shareholding value •••• Premium profile

About Rupa Khushmanlal Patel

Data last updated:

Rupa Khushmanlal Patel was a Director at P And B Pharmaceuticals Private Limited (2017–2025) and Director at P & B Laboratories Private Limited (2018–2025). The companies operate in Pharma.

DIN 08016379
Primary Designation Director
Industry Pharma
First Appointment 08 Dec 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Dec 20171978₹2.80 Cr (FY 2025)Active
P & B Laboratories Private Limited U24110MH1964PTC013023
Director31 Jan 20181964₹72.5 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
P And B Pharmaceuticals Private Limited
P & B Laboratories Private Limited
Premium access

Shareholding and investment profile for Rupa Khushmanlal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupa Khushmanlal Patel

Rupa Khushmanlal Patel was first appointed on 08 Dec 2017 as Director at P And B Pharmaceuticals Private Limited. The most recent appointment on record is 31 Jan 2018 at P & B Laboratories Private Limited.

Rupa Khushmanlal Patel held 2 earlier board appointments: P And B Pharmaceuticals Private Limited (Director, 08 Dec 2017 to 05 Mar 2025); P & B Laboratories Private Limited (Director, 31 Jan 2018 to 05 Mar 2025).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available